ADRA2A Antikörper
-
- Target Alle ADRA2A Antikörper anzeigen
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ADRA2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Reacts with the C-terminus part of human ADRA2A
- Kreuzreaktivität
- Maus, Ratte (Rattus)
- Kreuzreaktivität (Details)
- Cross reacts with mouse and rat protein.
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic peptide from human Adrenergic Receptor alpha-2A.
- Isotyp
- IgG
- Top Product
- Discover our top product ADRA2A Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: ELISA (1:20000), IF (1:100 - 1:500), IHC-P (10 μg/mL), WB (1:500 - 1:1000)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS (without Mg2+, Ca2+), pH 7.4, NaCl 150 mM, glycerol 50 % , Sodium azide 0.02 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for up to one year.
-
- Target
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
- Andere Bezeichnung
- ADRA2A (ADRA2A Produkte)
- Synonyme
- ADRA2A antikoerper, AW122659 antikoerper, Adra-2 antikoerper, Adra-2a antikoerper, alpha(2A)AR antikoerper, alpha2-C10 antikoerper, alpha2A antikoerper, alpha2A-AR antikoerper, ADRA2 antikoerper, ADRA2R antikoerper, ADRAR antikoerper, ALPHA2AAR antikoerper, ZNF32 antikoerper, CA2-47 antikoerper, RATRG20 antikoerper, RG20 antikoerper, PORA2AR antikoerper, adrenoceptor alpha 2A antikoerper, alpha-2A adrenergic receptor-like antikoerper, adrenergic receptor, alpha 2a antikoerper, adra2a antikoerper, ADRA2A antikoerper, LOC100414445 antikoerper, Adra2a antikoerper
- UniProt
- P08913
- Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
-